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THE ROLE OF CELLULAR ANTIOXIDANT PATHWAYS IN PROTECTING 
NEURONS DURING PHOTODYNAMIC THERAPY. 
 
James Phillips, The Open University, Milton Keynes, UK.  
 
The effect of photodynamic therapy (PDT) on neurons is an important consideration 
when treating cancers within or adjacent to the nervous system. The photosensitiser, 
meta-tetrahydroxyphenyl chlorin (mTHPC) is effective in destroying tumour cells but 
can spare neurons in culture. The aim of this study was to investigate the role of 
cellular antioxidant pathways in protecting neurons from damage during mTHPC-
mediated PDT.  
 
Exposing cells to 4 µg/ml mTHPC-mediated PDT in a 3D culture system resulted in 
substantial cell death among tumour cells and glia, but survival of neurons. To 
investigate this phenomenon, prior to PDT neurons were treated with drugs to block 
antioxidant pathways; L-buthionine sulfoximine (L-BSO) depleted glutathione, and 
diethyldithiocarbamate (DDC) and 2-methoxyoestradiol (2MeOE2) were used to 
inhibit superoxide dismutase SOD 1 and SOD 2 respectively. Neuronal cell death was 
assessed 24 h later.  
 
Neuronal death following mTHPC-mediated PDT was significantly increased in the 
presence of either DDC or L-BSO compared to PDT-only controls. There was a slight 
increase in neuronal death following PDT in neurons treated with 2-MeOE2, but this 
was not statistically significant. Overall, inhibition of glutathione resulted in 63 ± 7 % 
of neurons dying and inhibition of SOD 1 resulted in 42 ± 7 % neuron death. 
 
These results suggest that the mechanism by which neurons show reduced sensitivity 
to mTHPC-mediated PDT involves endogenous antioxidant pathways, the blocking of 
which results in neuronal cell death. Of the antioxidant pathways investigated here it 
is apparent that glutathione and SOD 1 play an important role, whereas inhibition of 
SOD 2 had little effect. Further studies are required to understand fully the cellular 
mechanisms involved in protecting neurons during this treatment, and the culture 
system described here is a useful tool for such research. Ultimately, understanding the 
conditions under which neurons may be able to survive PDT or other oxidative 
damage is important in developing strategies for treating tumours within or adjacent 
to the nervous system, where avoidance of neuronal damage has the potential to 
reduce side effects.  
  
